Sector Watch

GE Healthcare Launches Lullaby Phototherapy for Infant Jaundice Treatment

GE Healthcare recently launched Lullaby, a new blue compact fluorescent lamp (CFL) based phototherapy system for the treatment of indirect hyperbilirubinemia or jaundice in newborns. The Lullaby Phototherapy System (LPS), designed and developed at GE's R&D Centre in India, is part of their 'In India, for India' programme to make high-end technology more affordable, reliable and more accessible to larger sections of society.
GE Healthcare plans to export the LPS to Europe, Latin America, Middle East and Asia Pacific. The Company forecasts sales of 1,000 Lullaby units in India in the first year and plans to roll out new MIC products in early 2008. In addition, GE Healthcare recently announced the launch of new range of maternal-infant care (MIC) systems in association with Phoenix Medical Systems and SLE, UK to help support even the smallest centres in India. According to Omar Ishrak, President and CEO of GE Healthcare's Clinical Systems Business, "GE's clinical partnerships, technology leadership and continuous investment in healthcare solutions allow us to invite healthcare's top physicians to the drawing board to re-imagine healthcare solutions."

"As a part of our overall business strategy, we plan to tie up and acquire products in varied segments to become a complete solutions provider in the healthcare and life sciences space. With our recent tie up with Phoenix, we have now started manufacturing these products in India to expand our MIC portfolio. We plan to explore further opportunities to tap other potential segments," said V Raja, President and CEO, GE Healthcare, South Asia.
GE Healthcare is currently expanding its MIC and imaging product portfolio to achieve $800 million target by 2010 in India.

EH News Bureau